Business Description
Gelteq Ltd
NAICS : 325414
SIC : 2833
ISIN : AU0000218109
Total Employee Number:
8Description
Gelteq Ltd is a clinical and science-based company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care and other products, preserving the simplicity, accessibility, and efficacy of oral delivery. Its principal products are edible gels and their application in gel-based dosage forms across pets, sports, pharmaceutical, over-the-counter, and nutraceutical categories, leveraging its patent pending multiple ingredient dosage forms. The company develops and tests gel-based delivery systems for humans and pets and focuses on out-licensing its technology to companies to create products that can be manufactured and sold, while continuing to manufacture existing products under license on a white label basis.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Equity-to-Asset | 0.71 | |||||
Debt-to-Equity | 0.36 | |||||
Debt-to-EBITDA | -1.41 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | -1.14 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.9 | |||||
3-Year EBITDA Growth Rate | -19 | |||||
3-Year EPS without NRI Growth Rate | -24.7 | |||||
3-Year FCF Growth Rate | -56.9 | |||||
3-Year Book Growth Rate | -12.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 60.06 | |||||
9-Day RSI | 52.25 | |||||
14-Day RSI | 49.3 | |||||
3-1 Month Momentum % | 50.4 | |||||
6-1 Month Momentum % | -12.64 | |||||
12-1 Month Momentum % | -50.3 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.09 | |||||
Quick Ratio | 0.09 | |||||
Days Sales Outstanding | 59.14 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2 | |||||
Shareholder Yield % | -9.2 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Operating Margin % | -3933.33 | |||||
Net Margin % | -4315.74 | |||||
EBITDA Margin % | -2239.82 | |||||
FCF Margin % | -3715.74 | |||||
OCF Margin % | -3328.7 | |||||
ROE % | -44.21 | |||||
ROA % | -32.32 | |||||
ROIC % | -26.01 | |||||
3-Year ROIIC % | -463.51 | |||||
ROC (Joel Greenblatt) % | -32330 | |||||
ROCE % | -30.58 | |||||
Moat Score | 2 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 52.28 | |||||
PB Ratio | 0.65 | |||||
EV-to-EBIT | -3.04 | |||||
EV-to-EBITDA | -4.06 | |||||
EV-to-Revenue | 90.9 | |||||
EV-to-FCF | -2.45 | |||||
Earnings Yield (Greenblatt) % | -32.89 | |||||
FCF Yield % | -65.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:GELS
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gelteq Ltd Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.108 | ||
| EPS (TTM) ($) | -0.449 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 71.24 | ||
| 14-Day RSI | 49.3 | ||
| 14-Day ATR ($) | 0.062754 | ||
| 20-Day SMA ($) | 0.557883 | ||
| 12-1 Month Momentum % | -50.3 | ||
| 52-Week Range ($) | 0.387 - 2.02 | ||
| Shares Outstanding (Mil) | 10.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gelteq Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gelteq Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Second quarter earnings results for 2027 | 2027-02-26 | In 182 days | ||
| First quarter earnings results for 2027 | 2026-11-30 | In 94 days | ||
| Annual report for 2026 | 2026-11-17 | In 81 days | ||
| General meeting for 2026 | 2026-10-30 | In 63 days | ||
| Fourth quarter earnings results for 2026 | 2026-08-31 | In 3 days | ||
| Third quarter earnings results for 2026 | 2026-05-29 | 0.45 (+4.10%) | ||
| Annual report for 2025 | 2025-11-17 | 1.00 (+2.89%) | ||
| Annual report for 2024 | 2024-11-15 | 1.62 (+0.62%) |
Show
Entries
Gelteq Ltd Frequently Asked Questions
What is Gelteq Ltd(GELS)'s stock price today?
The current price of GELS is $0.57. The 52 week high of GELS is $2.02 and 52 week low is $0.39.
When is next earnings date of Gelteq Ltd(GELS)?
The next earnings date of Gelteq Ltd(GELS) is 2026-08-31 Est..
Does Gelteq Ltd(GELS) pay dividends? If so, how much?
Gelteq Ltd(GELS) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Gelteq Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers